Syra Health Corp. Class A ( (SYRA) ) has released its Q4 earnings. Here is a breakdown of the information Syra Health Corp. Class A presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syra Health Corp. is a healthcare technology company that focuses on improving health outcomes through innovative technology products and services, particularly in mental health, population health, and healthcare workforce sectors. In its latest earnings report, Syra Health announced a significant 45% increase in full-year revenue for 2024, reaching $8.0 million. The company also reported a notable reduction in net losses for the fourth quarter, highlighting efficiency gains and strategic growth. Key financial metrics showed a strong performance in the Population Health segment, which saw a 285% increase in Q4 revenue year-over-year, and a substantial decrease in operating expenses by 39% in the same period. The company also secured several new contracts and extensions, contributing to its sustainable growth trajectory. Looking ahead to 2025, Syra Health anticipates continued revenue growth driven by its higher-margin business units and aims to maintain its path towards profitability through strategic cost management and operational efficiencies.